Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
Why Is Arbe Robotics Ltd. (ARBE) Stock Down -7.94% Today?

Why Is Arbe Robotics Ltd. (ARBE) Stock Down -7.94% Today?

Key Takeaways

  • Arbe Robotics shares fell 7.94% to $0.3643 in Thursday's early session, a fresh low for the year.
  • The primary catalyst was a third-quarter revenue miss combined with a deep cut to full-year 2026 revenue guidance.
  • Management pushed two integration projects into 2027, deferring related purchase orders, deliveries and revenue.
  • Secondary pressure came from a projected 2026 adjusted EBITDA loss of $34 million–$35 million and continued investment in radar production capacity.
  • The selloff was company-specific: lidar peers OUST and AEVA traded higher, while shares remain below both their 50-day and 200-day moving averages.
  • News Significance Score: 42/100 — A material guidance reset met a move only about twice the stock's typical daily swing.
  • Traders are watching fourth-quarter delivery timing, the 2027 volume ramp on the China Level 3 program and quarterly cash burn against $48 million in liquidity.
  • Investors seeking deeper detail can review Price Targets, Earnings and Forecast pages for ARBE.
  • For a systematic view of momentum, explore Trending AI Robots, Tickeron's curated list of top-performing trading bots.

Opening Summary

Arbe Robotics Ltd. (ARBE) is a Tel Aviv-based developer of ultra-high-resolution 4D imaging radar chipsets and systems for automotive ADAS, robotaxis, defense and industrial sensing. Shares were trading at $0.3643 early Thursday, down 7.94% from the prior close of $0.3957, extending a decline that has erased roughly 70% of the company's value over the past year. The immediate cause was clear and verified: third-quarter revenue came in below expectations and management reset its 2026 revenue outlook sharply lower, citing integration delays that push two customer programs into 2027. Market capitalization is now roughly $46 million.

Earnings Results and a Sharply Lower 2026 Outlook

The quarterly numbers were mixed at the top and bottom line. Revenue of $752,000 more than doubled from $254,000 a year earlier but landed about 17% below the roughly $903,000 consensus. The adjusted loss per share of $0.06 beat the $0.07 expected, gross profit turned marginally positive at $17,000, operating expenses fell to $9.1 million from $11.3 million and the net loss narrowed to $9.0 million from $11.0 million.

The damage came from the outlook. Arbe trimmed full-year 2026 revenue guidance to $2.3 million–$3.0 million, down from a February range of $4 million–$6 million and well below the $4.12 million consensus — a cut of roughly 30% to 45% at the midpoint. Management said integration work on two projects originally expected to complete in the fourth quarter is still ongoing, with related orders, deliveries and revenue now shifting to 2027. Adjusted EBITDA for 2026 is guided to a loss of $34 million–$35 million.

Why the Guidance Cut Outweighed the Operational Wins

The quarter also contained genuine strategic progress: a major Chinese automotive group selected HiRain's imaging radar, built on Arbe's chipset, for a multi-brand Level 3 program, with series production deliveries slated for the fourth quarter of 2027. Defense momentum continued with initial orders from a global homeland security integrator and the launch of the Alerion counter-drone radar.

Those wins, however, are back-end loaded, and the revenue miss removes near-term proof points investors had been counting on. With trailing twelve-month revenue under $2 million against a valuation that still rests on future mass production, any delay in the conversion of design wins into billings compresses the multiple quickly. Management noted it remains in compliance with convertible debenture covenants and that liquidity of $48 million in cash and deposits sits well above required thresholds — a cushion that limits solvency risk but did not offset the growth reset.

Market Context and Trading Activity

Volume was heavy from the opening bell, with more than 200,000 shares changing hands in the first ten minutes against a 20-day average of roughly 800,000, consistent with an earnings-driven move rather than a thin-liquidity drift. Peer action confirms the move was idiosyncratic: OUST and AEVA both gained ground, showing no sector-wide risk-off impulse in automotive sensing.

Technically, the stock opened at $0.36, printed an intraday low of $0.3503 and traded near the bottom of its 52-week range. It remains well beneath its 50-day moving average near $0.54 and its 200-day average near $0.75, a structure that keeps momentum sellers in control and leaves little chart support until new basing forms. Short interest of roughly 11.2 million shares, about 10% of the float, adds two-way volatility without explaining the direction of today's move.

News Significance Score

The score runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. Arbe lands at 42 out of 100. The verified news was substantive: a revenue shortfall plus a 30%–45% reduction in full-year guidance is material for a company of this size, where the 2026 top line is the main test of the commercialization story. The price response, however, was not unusual by this stock's standards — the 7.94% decline was about 2.2 times the typical daily move of roughly 3.7%, and six of the prior 60 sessions posted equal or larger swings. Strong news, ordinary volatility, hence a middling score.

What Comes Next for ARBE

Attention now shifts to fourth-quarter execution: whether the two delayed integration projects begin converting to orders early in 2027, and whether the China Level 3 program stays on schedule for late-2027 series deliveries. Defense orders and the Alerion counter-drone launch are the fastest potential sources of near-term revenue, and management has flagged additional projects under evaluation.

Cash discipline is the other watch item, with a $34 million–$35 million EBITDA loss guide for 2026 against $48 million in liquidity. Analyst coverage remains thin at three firms with an average rating of Buy and considerable dispersion in targets, so estimate revisions over the coming weeks will matter more than usual. Risks include further program slippage, customer concentration among a handful of Tier-1 partners, competitive pressure in 4D radar and the possibility of additional equity financing if timelines slip again. No price targets are implied here.

Trending AI Robots

Tickeron operates hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions appear in its curated Trending AI Robots section. Bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, so the page offers a practical way to compare live approaches side by side. For investors navigating volatile small caps like ARBE, reviewing the trending list is a sensible next step before allocating capital.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ARBE

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ARBE in downward trend: price may decline as a result of having broken its higher Bollinger Band on November 11, 2026

ARBE broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 36 similar instances where the stock broke above the upper band. In 34 of the 36 cases the stock fell afterwards. This puts the odds of success at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARBE as a result. In 69 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARBE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for ARBE entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ARBE's RSI Indicator exited the oversold zone, 32 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for ARBE just turned positive on November 03, 2026. Looking at past instances where ARBE's MACD turned positive, the stock continued to rise in 34 of 45 cases over the following month. The odds of a continued upward trend are 76%.

Following a +14.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARBE advanced for three days, in 182 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.365) is normal, around the industry mean (1.448). P/E Ratio (-1.276) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (43.103) is also within normal values, averaging (32.028).

The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. ARBE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARBE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 7.99B. The market cap for tickers in the group ranges from 12.56K to 120.89B. KYCCF holds the highest valuation in this group at 120.89B. The lowest valued company is FLXT at 12.56K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was -3%. For the same Industry, the average monthly price growth was -11%, and the average quarterly price growth was -21%. AIMD experienced the highest price growth at 154%, while ARAI experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was 203%. For the same stocks of the Industry, the average monthly volume growth was 388% and the average quarterly volume growth was 229%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 50
Price Growth Rating: 62
SMR Rating: 78
Profit Risk Rating: 82
Seasonality Score: 7 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ElectronicEquipmentInstruments

Industry
N/A
Address
107 HaHashmonaim Street
Phone
+972 737969804
Employees
145
Web
https://www.arberobotics.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.